Application of an Electronic Nose in the Early Detection of ASpergillosis (AENEAS)

A

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Status

Completed

Conditions

Pulmonary Invasive Aspergillosis

Study type

Observational

Funder types

Other

Identifiers

NCT01395446
28062009

Details and patient eligibility

About

The purpose of this study is to establish the accuracy with which the eNose can discriminate patients with invasive pulmonary aspergillosis from controls.

Enrollment

52 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Patients that

  • are 18 years of age or older
  • will undergo treatment for a hematological malignancy expected to result in grade 4 neutropenia (according to CTCAE 3.0, i.e. <0.5 x 109 neutrophils/L) of prolonged duration (i.e., more than 7 days), e.g. hematopoietic stem cell transplantation or induction/consolidation treatment for acute myeloid leukaemia
  • have given written informed consent

Exclusion criteria

  • a previously diagnosed invasive mycosis
  • the inability to perform the breathing manoeuvre needed for eNose-analysis of exhaled air

Trial design

52 participants in 1 patient group

prolonged neutropenic patients
Description:
patients that will undergo treatment for a hematological malignancy expected to result in grade 4 neutropenia of prolonged duration

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems